ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
98.19
-0.85 (-0.85%)
Jul 24, 2026, 4:00 PM EDT - Market closed
BIB Holdings Information
BIB is an equity ETF with a total of 259 individual holdings.
Total Holdings
259
Top 10 Percentage
159.11%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
84.23M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 34.92% |
| 2 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 31.50% |
| 3 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 30.80% |
| 4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 20.89% |
| 5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 19.89% |
| 6 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 5.01% |
| 7 | AMGN | Amgen Inc. | 4.66% |
| 8 | VRTX | Vertex Pharmaceuticals Incorporated | 4.53% |
| 9 | GILD | Gilead Sciences, Inc. | 4.16% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 2.75% |
| 11 | RVMD | Revolution Medicines, Inc. | 1.59% |
| 12 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.46% |
| 13 | BIIB | Biogen Inc. | 1.19% |
| 14 | ILMN | Illumina, Inc. | 1.18% |
| 15 | RPRX | Royalty Pharma plc | 1.07% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.03% |
| 17 | ARGX | argenx SE | 0.96% |
| 18 | INCY | Incyte Corporation | 0.95% |
| 19 | INSM | Insmed Incorporated | 0.95% |
| 20 | MRNA | Moderna, Inc. | 0.94% |
| 21 | UTHR | United Therapeutics Corporation | 0.92% |
| 22 | GH | Guardant Health, Inc. | 0.82% |
| 23 | VTRS | Viatris Inc. | 0.81% |
| 24 | NBIX | Neurocrine Biosciences, Inc. | 0.71% |
| 25 | BBIO | BridgeBio Pharma, Inc. | 0.66% |
As of Jul 22, 2026